Long-Term, Open-Label Extension Study to Evaluate the Safety and Tolerability of NBI-827104 in Pediatric Subjects with Epileptic Encephalopathy with Continuous Spike-and-Wave During Sleep
Clinical Trial Grant
Administered By
Pediatrics, Neurology
Awarded By
Neurocrine Biosciences, Inc.
Start Date
May 20, 2022
End Date
August 5, 2025
Administered By
Pediatrics, Neurology
Awarded By
Neurocrine Biosciences, Inc.
Start Date
May 20, 2022
End Date
August 5, 2025